Brink Therapeutics
PrivateLast Round
Seed
Apr 16, 2025
Total Funding Raised
$3.99M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Brink Therapeutics operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Seed round in April 2025.
Brink Therapeutics is a biotechnology company developing a gene-editing platform centered on the discovery and development of therapeutic recombinases for cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brink Therapeutics Comparables
Compare Brink Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seamless Therapeutics | 85% | |
| IntegraTherapeutics | 81% | |
| Komo Biosciences | 81% |
For institutional investors. Book with your work email.
Brink Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Brink Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kima Ventures | Seed |
| Plug and Play Tech Center | Seed |
| Breega | Seed |
| Kurma Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 139% MoM, reaching 2.9K.
- Apr 17, 2026
Grew 38% QoQ, from 8 to 11 employees.
For institutional investors. Book with your work email.
Brink Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Brink Therapeutics's valuation, stock price, and market status.
Is Brink Therapeutics a public or private company?
Brink Therapeutics is a private company.
What is the current stock price of Brink Therapeutics?
Brink Therapeutics is a private company, so its shares have no public market price. Caplight tracks Brink Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Brink Therapeutics worth (valuation)?
Valuation information for Brink Therapeutics is not publicly available.
Can I buy Brink Therapeutics stock?
Brink Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Brink Therapeutics's last funding round?
Brink Therapeutics's most recent funding round was Seed on April 16, 2025.
Who are the main investors in Brink Therapeutics?
Key investors in Brink Therapeutics include Breega, Kurma Partners.
Will Brink Therapeutics IPO soon?
No public IPO plans have been announced for Brink Therapeutics.
How can I track Brink Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Brink Therapeutics's shares on secondary markets.